Treatment of Generalized Dystonia

@article{Lubarr2011TreatmentOG,
  title={Treatment of Generalized Dystonia},
  author={Naomi Lubarr and Susan Bressman},
  journal={Current Treatment Options in Neurology},
  year={2011},
  volume={13},
  pages={274-289}
}
Opinion statementThe armamentarium for clinicians treating patients with generalized dystonia, previously restricted to only a few oral medications that often caused intolerable side effects, has been radically expanded in the past decade with the widespread application of deep brain stimulation (DBS). With DBS, patients who in the past would have been restricted to a life of severe motor disability from a young age can now lead lives with only minimal symptoms. Although DBS should therefore be… Expand
Surgical treatment for secondary dystonia
  • T. Tierney, A. Lozano
  • Medicine
  • Movement disorders : official journal of the Movement Disorder Society
  • 2012
TLDR
Surgical treatment options for this group of diverse conditions, including tardive dystonia, dystonic cerebral palsy, and certain heredodegenerative diseases in which deep brain stimulation and ablative lesions of the posteroventral pallidum have been shown to be effective are discussed. Expand
Dystonia and leveraging oral pharmacotherapy
TLDR
Treatment of dystonia primarily involves agents that target dopamine and acetylcholine receptors, and most of the widely used drugs have low levels of evidence and are primarily based on anecdotal experiences. Expand
l-Dopa in dystonia
TLDR
It is suggested to use l-dopa after biochemical corroboration of a defect in dopamine biosynthesis, in genetically confirmed DRD, or if nigrostriatal degeneration has been demonstrated by nuclear imaging in adults presenting with lower limb dystonia. Expand
Evaluation of the efficacy of deep brain stimulation in the surgical treatment of cervical dystonia.
TLDR
Pallidal DBS is a valid and effective second-line treatment for patients with cervical focal dystonia and its use in patients with an insufficient response to medical treatment is supported. Expand
Lessons Learned from Open-label Deep Brain Stimulation for Tourette Syndrome: Eight Cases over 7 Years
TLDR
The open-label experience with eight patients with severe refractory malignant TS treated with DBS supports the urgent need for more data and refinements in interventions and outcome measurements for severe, malignant, and medication-refracted TS. Expand
Deep Brain Stimulation of the Subthalamic and Entopeduncular Nuclei in an Animal Model of Tardive Dyskinesia
TLDR
It is shown that acute DBS applied to the subthalamic nucleus (STN) or the entopeduncular nucleus (EPN) suppresses VCMs without affecting locomotor activity, suggesting that DBS is not equivalent to functional inactivation. Expand
Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies.
TLDR
A systems-based approach to management of complications that result from leukodystrophies is presented and the need for future research on evidence-based outcomes to better treat the manifestations of this unique set of genetic disorders is underscored. Expand
Lesch-Nyhan Syndrome: Models, Theories, and Therapies
TLDR
New technologies such as next-generation sequencing, optogenetics, genome editing, and induced pluripotent stem cells provide a unique opportunity to map the precise sequential pathways leading from genotype to phenotype in Lesch-Nyhan syndrome. Expand
Early gene mapping after deep brain stimulation in a rat model of tardive dyskinesia: Comparison with transient local inactivation
TLDR
The results confirm the effectiveness of DBS in reducing VCMs and suggest that tissue inactivation does not fully account for DBS effects in this preparation, and the divergent effects of STN vs. EPN manipulations on HAL-induced zif268 changes suggest that similar behavioral outcomes ofDBS in these two areas may involve different neuroanatomical mechanisms. Expand
Bilateral Globus Pallidus Interna Deep‐Brain Stimulation in a Patient With Myoclonus‐Dystonia: A Case Report
TLDR
A case of the epsilon‐sarcoglycan mutation‐negative myoclonus‐dystonia patient who underwent bilateral globus pallidus interna deep‐brain stimulation with subsequent improvement of both myoconus and dystonia is reported. Expand
...
1
2
...

References

SHOWING 1-10 OF 66 REFERENCES
Management of status dystonicus: Our experience and review of the literature
TLDR
It is believed that a rapid and aggressive approach is justified to avoid the great morbidity and mortality which characterize Status dystonicus. Expand
Pallidal Deep Brain Stimulation for Primary Dystonia in Children
TLDR
Pallidal DBS is a safe and effective treatment for PGD in patients <21 years of age and the improvement appears durable, and improvement in device design should reduce hardware-related complications over time. Expand
Outcome predictors of pallidal stimulation in patients with primary dystonia: the role of disease duration.
TLDR
This study confirms that patients with primary, medically refractory dystonia are generally outstanding candidates for pallidal DBS, with the possible exception of axial FSD. Expand
A Case of Secondary Dystonia Responding to Levodopa
TLDR
The authors believe that in the pediatric population with secondary dystonias other than Segawa disease, a therapeutic trial with levodopa should be considered in some instances. Expand
Chronic deep brain stimulation in patients with tardive dystonia without a history of major psychosis
TLDR
Chronic pallidal DBS in patients with tardive dystonia without a history of major psychosis provides sustained improvement which is similar to that in other subgroups of patients with gynaecological problems, and this effect is stable on extended follow‐up for up to 3 years. Expand
Which patients with dystonia benefit from deep brain stimulation? A metaregression of individual patient outcomes
TLDR
Emphasis should be placed on both safety of surgical technique and an in-depth evaluation of patients' own perception of their life before and after DBS by using validated quality of life measures, in addition to existing use of objective severity scales. Expand
An open trial of levetiracetam for segmental and generalized dystonia
TLDR
The efficacy of levetiracetam in a daily dose of 3000 mg in 10 consecutive patients with otherwise therapy refractory segmental or generalized dystonia is studied. Expand
Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia.
TLDR
These findings support the efficacy and safety of the use of bilateral stimulation of the internal globus pallidus in selected patients with primary generalized dystonia. Expand
Deep brain stimulation for torsion dystonia.
TLDR
The classification and treatment of torsion dystonia is reviewed including the current indications for DBS surgery and details of theDBS procedure and programming of the DBS devices are discussed. Expand
Long-term effects of pallidal deep brain stimulation in tardive dystonia
TLDR
Pallidal deep brain stimulation is a safe and effective long-term treatment in patients with medically refractory tardive dystonia on motor function, quality of life (QoL), and mood. Expand
...
1
2
3
4
5
...